Squaring the drug development circle

    loading  Checking for direct PDF access through Ovid

Abstract

Governments, in the industrialised world at least, struggle to square the drug development circle. The growing pressure on healthcare budgets means purchasers seek to control drug costs. However, the pharmaceutical industry is one of the most successful industrial sectors and governments want to maintain a supportive research and development (R&D) environment. To resolve this tension, policy-makers need accurate estimates of the cost of pharmaceutical R&D.

Related Topics

    loading  Loading Related Articles